Insights from 2023 ASCO® Annual Meeting

 

Breast
14:37

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Practical Implications of SONIA Trial Results on the Use of CDK4/6i for Patients With ABC"

FEATURING Nagi El Saghir
  • 533 views
  • August 3, 2023
  • 4
09:50

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Randomised Open-Label Phase II FAIM Study - Induction Standard of Care Fulvestrant & CDK4/6i With Addition of Ipatasertib in ER+/HER2- mBC Patients Without ctDNA Suppression"

FEATURING Iseult Browne
  • 87 views
  • August 3, 2023
09:52

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Real-World Patient Characteristics & Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ mBC"

FEATURING Jane Meisel
  • 285 views
  • July 24, 2023
  • 1
29:14

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Breast Cancer Surgery - Too Much, Too Little, or Just Right?"

FEATURING Seema Khan
  • 136 views
  • July 5, 2023
  • 3
06:37

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 1b Trial Evaluating the Safety of Ribociclib, Tucatinib, & Trastuzumab for HER2+ mBC & Phase 2 Study of Preoperative Treatment With Ribociclib, Trastuzumab, Tucatinib +/- Fulvestrant vs. Docetaxel, Carboplatin, Trastuzumab, & Pertuzumab for HR+/-, HER2+ BC"

FEATURING Nicholas McAndrew
  • 307 views
  • June 29, 2023
  • 1
04:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BRCA Alterations - Beyond Breast and Ovarian Cancer"

FEATURING Timothy Yap
  • 139 views
  • June 21, 2023
  • 1
04:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "evERA Breast Cancer Phase III Study - Giredestrant + Everolimus vs. Exemestane + Everolimus in Pts With ER+/HER2- Locally Advanced or Metastatic BC"

FEATURING Erica Mayer
  • 272 views
  • June 21, 2023
  • 3
06:17

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Results From the Randomized Phase 3 OLIGO Study - High Dose Alkylating Chemo for Pts With Oligometastatic BC Harboring HRD"

FEATURING Annemiek Van Ommen - Nijhof
  • 117 views
  • June 16, 2023
09:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Outcome Analysis of the Phase 3 SONIA Trial - Selecting the Optimal Position of CDK4/6i for Pts With HR+/HER2- Advanced BC"

FEATURING Noor Wortelboer
  • 66 views
  • June 16, 2023
08:51

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Effects of Ovarian Ablation or Suppression on BC Recurrence and Survival - Patient-Level Meta-Analysis of 14,993 Pre-Menopausal Women in 25 Randomized Trials"

FEATURING Richard Gray
  • 333 views
  • June 16, 2023
  • 3
07:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The X-7/7 Randomized Trial - Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in mBC"

FEATURING Colleen Bohnenkamp
  • 362 views
  • June 16, 2023
  • 2
23:03

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Neoadjuvant Therapy in TNBC - Where We Are and What's Next?"

FEATURING Erica Stringer-Reasor
  • 378 views
  • June 15, 2023
  • 6
10:02

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Double-Blind, Placebo-Controlled Phase 3 AIPAC-003 Trial - Testing Eftilagimod Alpha in Pts With HER2-/Low mBC Receiving Paclitaxel, Following an Open-Label Dose Optimization"

FEATURING Nuhad Ibrahim
  • 60 views
  • June 15, 2023
  • 1
05:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Prognostic Impact of Adjuvant Endocrine Therapy for ER+/HER2- T1a/bN0M0 BC"

FEATURING Yuko Takahashi
  • 104 views
  • June 15, 2023
  • 3
08:41

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "10-Year Update of the Short-HER Phase III Randomized Trial - Nine-Weeks vs. One-Year Trastuzumab for Early-Stage HER2+ BC"

FEATURING Pierfranco Conte
  • 760 views
  • June 15, 2023
  • 3
12:23

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: Role of Endocrine Therapy Timing Intake in Pts With ER+ HER2- Breast Cancers

FEATURING Sylvie Giacchetti
  • 644 views
  • June 15, 2023
  • 6
07:17

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Results of NCCH1607/PATHWAY, an Asian International Double-Blind Randomized Phase 3 Trial - Palbociclib + Tamoxifen ± Goserelin in Women With HR+/HER2- Advanced BC"

FEATURING Takahiro Kogawa
  • 111 views
  • June 14, 2023
07:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Randomized Controlled Trial Comparing Primary Tumor Resection + Systemic Therapy With Systemic Therapy Alone in mBC (PRIM-BC) - Japan Clinical Oncology Group Study JCOG1017"

FEATURING Tadahiko Shien
  • 355 views
  • June 14, 2023
  • 3
13:15

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Biomarkers Predicting Response to 5 IO Arms in the Neoadjuvant I-SPY2 Trial for eBC - Evaluation of Immune Subtyping in the Response Predictive Subtypes"

FEATURING Denise Wolf
  • 104 views
  • June 14, 2023
  • 1
13:20

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "lidERA Breast Cancer Phase III Adjuvant Study - Giredestrant vs. Physician’s Choice of ET for ER+/HER2- eBC"

FEATURING Charles Geyer
  • 345 views
  • June 14, 2023
  • 2
10:50

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "MammaPrint Index as a Predictive Biomarker for Neoadjuvant Chemo Response & Outcome in Patients With HR+/HER2- BC in NBRST"

FEATURING William Audeh
  • 239 views
  • June 14, 2023
  • 2
16:42

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Late Recurrences in ER+ Breast Cancer - What Else Can We Do?

FEATURING Michael Gnant
  • 643 views
  • June 14, 2023
  • 3
11:31

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Top 5 Abstracts Summary: "SONIA, NATALEE, PHERGain, TROPICS-02, and DESTINY-PANTUMOR-02"

FEATURING Paolo Tarantino
  • 8,195 views
  • June 12, 2023
  • 41
05:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Final Results of the Phase 3 SAFE Trial - Pharmacological Cardioprotective Strategy for Non-Metastatic Patients Affected by BC Receiving an Anthracycline-Based Chemo"

FEATURING Carlotta Becherini, Lorenzo Livi
  • 207 views
  • June 12, 2023
  • 2
23:58

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "mBC Expert Panel Discussion on Key Trials Including SONIA & PALMIRA"

FEATURING Hope Rugo, Komal Jhaveri
  • 1,921 views
  • June 9, 2023
  • 14
28:36

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "eBC Expert Panel Discussion on Key Trials Including NATALEE & PHERGain"

FEATURING Hope Rugo, Komal Jhaveri
  • 4,824 views
  • June 9, 2023
  • 18
13:35

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Subgroup Analysis of the RIGHT Choice Trial - Outcomes With 1L Ribociclib + ET vs. Physician’s Choice Combination Chemo by Age in Pre/Perimenopausal Pts With Aggressive HR+/HER2- aBC"

FEATURING Nagi El Saghir
  • 262 views
  • June 9, 2023
  • 2
06:57

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Existing Resistance Variants on Clinical Outcomes in Patients With mBC"

FEATURING Arielle Medford
  • 830 views
  • June 9, 2023
  • 2
06:55

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Comparative OS of Pts in Trials of CKD4/6i in Combination With ET in Advanced BC"

FEATURING Coralea Kappel
  • 325 views
  • June 9, 2023
  • 1
08:00

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Primary Efficacy Analyses of NeoRHEA, Neoadjuvant Biomarker Research Study of Palbociclib Combined With ET in ER+/HER2- BC"

FEATURING Michail Ignatiadis
  • 217 views
  • June 9, 2023
  • 2
11:13

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Are We Splitting HERs? The Highs and Lows"

FEATURING David Rimm
  • 231 views
  • June 8, 2023
  • 4
16:08

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Tailoring Post-Neoadjuvant Therapy in TNBC"

FEATURING Hyo Han
  • 854 views
  • June 8, 2023
  • 5
08:38

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Utility of Ki67 in Guiding Adjuvant Abemaciclib Therapy for Patients With HR+, eBC"

FEATURING Rima Patel
  • 817 views
  • June 8, 2023
  • 4
07:47

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "BC Staging for Patients With 'Low-Risk' Disease - Are They All the Same?"

FEATURING Jennifer Plichta
  • 292 views
  • June 7, 2023
  • 4
02:59

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Oral Elacestrant vs. Standard-of-Care in ER+/HER2- Advanced or mBC Without Detectable ESR1 Mutation (EMERALD) - Subgroup Analysis by Prior Duration of CDK4/6i + ET"

FEATURING Virginia Kaklamani
  • 113 views
  • June 7, 2023
  • 3
09:32

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "TROPiCS-02 Phase 3 Study Final OS Analysis - Sacituzumab Govitecan in Pts With HR+/HER2- mBC"

FEATURING Sara Tolaney
  • 704 views
  • June 7, 2023
  • 7
04:28

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "ASCENT-05/OptimICE-RD (AFT-65): Adjuvant Sacituzumab Govitecan + Pembro vs Pembro ± Capecitabine in TNBC and Residual Disease After Neoadjuvant Therapy and Surgery"

FEATURING Sara Tolaney
  • 2,290 views
  • June 7, 2023
  • 4
12:48

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Association of Tumor-Infiltrating Lymphocytes With Clinicopathologic Characteristics and Prognosis in Young Women With HR+/HER2- BC"

FEATURING Megan Tesch
  • 119 views
  • June 7, 2023
  • 2
05:21

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pertuzumab Retreatment in Patients With HER2+ Locally Advanced/Metastatic BC: OS Results of a Phase 3 Randomized Trial (JBCRG-M05: PRECIOUS)"

FEATURING Yutaka Yamamoto
  • 381 views
  • June 6, 2023
  • 1